[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fAXKLDtm4CTIB22TFGaT-NGH3V_RC-xaOEIA-JjimXcM":3,"$fH1Gq2iGL3UQ9kYIpfxkYL1cgz1dPTIvdmViWpBTMH-Q":129},{"company":4,"items":17,"total":14},{"id":5,"slug":6,"company_name":7,"website_url":8,"country_code":9,"source_name":10,"source_url":11,"profile_summary":8,"legal_name":8,"legal_form":8,"registry_court":8,"registry_number":8,"vat_id":8,"impressum_address":8,"enrichment_sources_json":8,"enrichment_model":8,"enrichment_updated_at":8,"enrichment_error":8,"first_seen_at":12,"updated_at":13,"award_count":14,"total_value_eur":15,"latest_award_at":16},3511,"originalis-b-v","Originalis B.V.",null,"NLD","ted-v3","https://ted.europa.eu/de/notice/-/detail/367392-2026","2026-06-11 06:06:45","2026-07-11 23:57:11",10,1,"2026-07-08T00:00:00.000Z",[18,37,49,60,67,76,86,97,108,119],{"award_id":19,"tender_id":20,"source_name":10,"source_award_id":21,"source_url":22,"award_notice_type":23,"award_date":24,"publication_date":16,"lot_number":25,"contract_title":26,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":32,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":36,"tender_deadline_utc":8},480964,151181,"469114-2026","https://ted.europa.eu/de/notice/-/detail/469114-2026","can-standard","2025-08-01T00:00:00.000Z","LOT-0001","Nilotinib (ausgenommen als Dispersion in Apfelmus), ATC L01EA03","KvK 57949255","EUR",0.97,"public","free","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nilotinib (ausgenommen als DISP in Apfelmus) f. d. Z. 01.8.25 - 31.7.27 (zzgl. Verlängerungsoption 1x12 Mon.)","DAK-Gesundheit","DE","33600000","2026-07-07T22:00:00.000Z",{"award_id":38,"tender_id":39,"source_name":10,"source_award_id":40,"source_url":41,"award_notice_type":23,"award_date":42,"publication_date":43,"lot_number":25,"contract_title":44,"winner_name":7,"winner_identifier":45,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":46,"buyer_name":33,"region_code":47,"cpv_code":35,"tender_published_at_utc":48,"tender_deadline_utc":8},479827,153042,"460579-2026","https://ted.europa.eu/de/notice/-/detail/460579-2026","2024-07-01T00:00:00.000Z","2026-07-03T00:00:00.000Z","Dornase alfa, ATC R05CB13","KVK 57948255","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dornase alfa, ATC R05CB13 für die Zeit 01.07.2024 - 30.06.2026","DE-HH","2026-07-02T22:00:00.000Z",{"award_id":50,"tender_id":51,"source_name":10,"source_award_id":52,"source_url":53,"award_notice_type":23,"award_date":54,"publication_date":55,"lot_number":25,"contract_title":56,"winner_name":7,"winner_identifier":57,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":58,"buyer_name":33,"region_code":47,"cpv_code":35,"tender_published_at_utc":59,"tender_deadline_utc":8},427775,144038,"410286-2026","https://ted.europa.eu/de/notice/-/detail/410286-2026","2024-04-01T00:00:00.000Z","2026-06-16T00:00:00.000Z","Dexamethason (ausschließlich IMP), ATC S01BA01","KvK: 57949255","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dexamethason (ausschließlich IMP), ATC S01BA01 für die Zeit 01.04.2024 - 31.03.2026","2026-06-15T22:00:00.000Z",{"award_id":61,"tender_id":62,"source_name":10,"source_award_id":63,"source_url":64,"award_notice_type":23,"award_date":54,"publication_date":55,"lot_number":25,"contract_title":65,"winner_name":7,"winner_identifier":57,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":66,"buyer_name":33,"region_code":47,"cpv_code":35,"tender_published_at_utc":59,"tender_deadline_utc":8},427791,143623,"410574-2026","https://ted.europa.eu/de/notice/-/detail/410574-2026","Interferon beta-1b, ATC L03AB08","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Interferon beta-1b, ATC L03AB08 für die Zeit 01.04.2024 - 31.03.2026",{"award_id":68,"tender_id":69,"source_name":10,"source_award_id":70,"source_url":71,"award_notice_type":23,"award_date":72,"publication_date":55,"lot_number":25,"contract_title":73,"winner_name":7,"winner_identifier":74,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":75,"buyer_name":33,"region_code":47,"cpv_code":35,"tender_published_at_utc":59,"tender_deadline_utc":8},469268,144005,"413359-2026","https://ted.europa.eu/de/notice/-/detail/413359-2026","2025-03-01T00:00:00.000Z","Pegfilgrastim, ATC L03AA13","57949255","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pegfilgrastim, ATC L03AA13 für die Zeit 01.03.2025 - 28.02.2026 (zzgl. Verlängerungsoption 1x12 Monate)",{"award_id":77,"tender_id":78,"source_name":10,"source_award_id":79,"source_url":11,"award_notice_type":23,"award_date":80,"publication_date":81,"lot_number":25,"contract_title":82,"winner_name":7,"winner_identifier":83,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":84,"buyer_name":33,"region_code":47,"cpv_code":35,"tender_published_at_utc":85,"tender_deadline_utc":8},379983,24791,"367392-2026","2024-06-01T00:00:00.000Z","2026-05-29T00:00:00.000Z","Bexaroten, ATC L01XF03","KvK-Nr. 57949255","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bexaroten, ATC L01XF03 für die Zeit 01.06.2024 - 31.05.2026","2026-05-28T22:00:00.000Z",{"award_id":87,"tender_id":88,"source_name":10,"source_award_id":89,"source_url":90,"award_notice_type":23,"award_date":91,"publication_date":92,"lot_number":25,"contract_title":93,"winner_name":7,"winner_identifier":94,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":95,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":96,"tender_deadline_utc":8},508278,40196,"65166-2026","https://ted.europa.eu/de/notice/-/detail/65166-2026","2024-02-01T00:00:00.000Z","2026-01-29T00:00:00.000Z","Follitropin alfa, ATC G03GA05","KvK57949255","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Follitropin alfa, ATC G03GA05 für die Zeit 01.02.2024 - 31.01.2026","2026-01-28T23:00:00.000Z",{"award_id":98,"tender_id":99,"source_name":10,"source_award_id":100,"source_url":101,"award_notice_type":23,"award_date":102,"publication_date":103,"lot_number":25,"contract_title":104,"winner_name":7,"winner_identifier":105,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":106,"buyer_name":33,"region_code":47,"cpv_code":35,"tender_published_at_utc":107,"tender_deadline_utc":8},350262,42651,"19342-2026","https://ted.europa.eu/de/notice/-/detail/19342-2026","2025-05-01T00:00:00.000Z","2026-01-13T00:00:00.000Z","Peginterferon beta-1a, ATC L03AB13","KVK 57949255","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Peginterferon beta-1a, ATC L03AB13 für die Zeit 01.05.2025 - 30.04.2027","2026-01-12T23:00:00.000Z",{"award_id":109,"tender_id":110,"source_name":10,"source_award_id":111,"source_url":112,"award_notice_type":23,"award_date":8,"publication_date":113,"lot_number":8,"contract_title":114,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":8,"currency":8,"confidence":115,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":116,"buyer_name":117,"region_code":34,"cpv_code":35,"tender_published_at_utc":118,"tender_deadline_utc":8},54247,25189,"585799-2025","https://ted.europa.eu/de/notice/-/detail/585799-2025","2025-09-08T00:00:00.000Z","Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der Originalis B.V. zu Betaferon",0.92,"Deutschland – Arzneimittel – Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der Novartis Pharma GmbH zu Rhapsido","IKK classic","2026-05-27T22:00:00.000Z",{"award_id":120,"tender_id":121,"source_name":10,"source_award_id":122,"source_url":123,"award_notice_type":23,"award_date":8,"publication_date":124,"lot_number":25,"contract_title":125,"winner_name":7,"winner_identifier":105,"winner_country":126,"value_eur":15,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":127,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":128,"tender_deadline_utc":8},358358,83045,"221805-2025","https://ted.europa.eu/de/notice/-/detail/221805-2025","2025-04-07T00:00:00.000Z","Ranolazin, ATC C01EB18","DEU","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ranolazin, (OBG) ATC C01EB18 für die Zeit 01.02.2025 - 31.03.2025","2025-04-06T22:00:00.000Z",{"company_slug":6,"years":130,"award_count":14,"top_buyers":131,"yearly_trend":140},5,[132,136],{"buyer_name":33,"buyer_key":133,"award_count":134,"total_value_eur":15,"share_count":135},"dak-gesundheit",9,0.9,{"buyer_name":117,"buyer_key":137,"award_count":15,"total_value_eur":138,"share_count":139},"ikk-classic",0,0.1,[141,144],{"year":142,"award_count":143},2025,2,{"year":145,"award_count":146},2026,8]